The study found dangers surrounding GLP-1RA use in sport settings including experimental dosing, cycling or stacking different GLP-1RAs, and combining anabolic androgenic steroids with GLP-1RAs to avoid muscle waste
Scenario 2: supply and cost constraints The medication landscape for GLP-1 agonists is volatile
Some people report mild digestive discomfort, particularly when starting at higher doses
It means a 0.25mg weekly injection delivers more systemic semaglutide than a 1mg daily sublingual dose in many cases
Note that this is considered off label and risks reduced efficacy, fluctuating appetite control, weight regain, glycaemic deterioration and dosing errors
In breast cancer cells, luteolin activates ERK and p38 MAPK pathways, and their inhibition or knockdown reduces luteolin-induced cell death, while caspase-3 inhibition has no effect